Literature DB >> 5880358

The developing motor end-plate: curare tolerance in the chick embryo.

D B Drachman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5880358      PMCID: PMC1357418          DOI: 10.1113/jphysiol.1965.sp007727

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  11 in total

Review 1.  IMPLICATIONS ON ENZYME INDUCTION FOR DRUG THERAPY.

Authors:  J J BURNS
Journal:  Am J Med       Date:  1964-09       Impact factor: 4.965

2.  THE DEVELOPING MOTOR END-PLATE: PHARMACOLOGICAL STUDIES IN THE CHICK EMBRYO.

Authors:  D B DRACHMAN
Journal:  J Physiol       Date:  1963-12       Impact factor: 5.182

3.  Experimental clubfoot and arthrogryposis multiplex congenita.

Authors:  D B DRACHMAN; A J COULOMBRE
Journal:  Lancet       Date:  1962-09-15       Impact factor: 79.321

4.  Method for continuous infusion of fluids into the chorioallantoic circulation of the chick embryo.

Authors:  D B DRACHMAN; A J COULOMBRE
Journal:  Science       Date:  1962-10-12       Impact factor: 47.728

5.  Supersensitivity of skeletal muscle produced by botulinum toxin.

Authors:  S THESLEFF
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

6.  Enzymic activity during early development.

Authors:  D RICHTER
Journal:  Br Med Bull       Date:  1961-05       Impact factor: 4.291

7.  The induction of arginase activity in the chick embryo.

Authors:  M ROEDER
Journal:  J Cell Comp Physiol       Date:  1957-10

8.  Cytological localization of cholinesterase in developing chick embryo skeletal muscle.

Authors:  M MUMENTHALER; W K ENGEL
Journal:  Acta Anat (Basel)       Date:  1961

9.  Curarization of denervated muscle.

Authors:  L W JARCHO; B BERMAN; C EYZAGUIRRE; J L LILIENTHAL
Journal:  Ann N Y Acad Sci       Date:  1951-10       Impact factor: 5.691

10.  ATROPHY OF SKELETAL MUSCLE IN CHICK EMBRYOS TREATED WITH BOTULINUM TOXIN.

Authors:  D B DRACHMAN
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.